Hepatitis B Virus Screening Before Cancer Chemotherapy in Taiwan: A Nationwide Population-Based Study

Background: Reactivation of the hepatitis B virus (HBV) during cancer chemotherapy is a severe and sometimes fatal complication. In 2009, the National Health Insurance (NHI) in Taiwan recommended and reimbursed screening for HBV infection and prophylactic antiviral therapy before cancer chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wei-Chih, Tang, Pei-Ling, Chen, Wen-Chi, Tsay, Feng-Woei, Wang, Huay-Min, Tsai, Tzung-Jiun, Kao, Sung-Shuo, Cheng, Jin-Shiung, Tsai, Wei-Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319464/
https://www.ncbi.nlm.nih.gov/pubmed/34336877
http://dx.doi.org/10.3389/fmed.2021.657109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319464/
https://www.ncbi.nlm.nih.gov/pubmed/34336877
http://dx.doi.org/10.3389/fmed.2021.657109

Ejemplares similares